Giulia Alagna: Managing Coronary Aneurysmal and Ectatic Disease
Giulia Alagna, Interventional Cardiologist at ASL VCO, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in The American Journal of Cardiology, adding:
“New publication in The American Journal of Cardiology.
This work focuses on coronary aneurysmal and ectatic disease (CAA/CAE), an increasingly recognized condition in contemporary catheterization laboratory practice that still represents a significant diagnostic and therapeutic challenge.
A sincere thank you to my co-authors Francesca Campanella, Lucio Giuseppe Granata, Pierre F. Sabouret, Alessandro Lupi, Giuseppe Andò for their valuable contributions and for sharing this project with me.
What did we focus on?
We aimed to provide a practical framework for the management of these patients, from pathophysiology to treatment, with particular emphasis on the aspects most relevant to everyday Cath Lab practice.
A central role is played by intravascular imaging (IVUS and OCT). Angiography alone may not adequately characterize vessel dimensions, aneurysm morphology, or intraluminal thrombus.
Intravascular imaging can also help distinguish true aneurysms from pseudoaneurysms and guide procedural planning when PCI is required.
What about antithrombotic therapy?
This remains one of the most controversial aspects of management.
Our systematic appraisal of the available literature shows that current evidence does not support routine oral anticoagulation in unselected patients with coronary aneurysmal disease.
Antiplatelet-based therapy therefore remains the cornerstone of treatment, while oral anticoagulation may be considered, off-label, in selected high-risk scenarios, such as documented intraluminal thrombus, recurrent ischemic events despite adequate antiplatelet therapy, or very large/diffuse aneurysmal disease.
Revascularization also cannot follow a ‘one-size-fits-all’ strategy.
PCI should primarily target flow-limiting or culprit lesions, preferably with intravascular imaging guidance, while giant aneurysms and particularly complex anatomies may require surgical evaluation and multidisciplinary Heart Team discussion.
The key message of our work is therefore straightforward: There is no single treatment strategy that fits every patient.
Clinical presentation, coronary anatomy, thrombus burden, ischemic risk, and bleeding risk should all be integrated into an individualized, phenotype-driven approach.”
Title: Coronary Aneurysmal and Ectatic Disease: Cath-Lab Diagnosis and Contemporary Interventional Management
Authors: Giulia Alagna, Francesca Campanella, Lucio Giuseppe Granata, Pierre Sabouret, Alessandro Lupi, Giuseppe Andò

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 00:33Overcoming Barriers to Diagnosis and Treatment for Women With Bleeding Disorders – EHC
-
Nov 20, 2026, 00:27Vera Stroikova: Key Takeaways on Electrophysiology and Stroke Prevention From the New Horizons 2026
-
Nov 20, 2026, 00:20Devi G. Nair Enrolls First US Patient in Smartphone Camera Atrial Fibrillation Detection Study
-
Nov 20, 2026, 00:14Saskia de Pee: Fortified Rice Cuts Anemia Risk by 57%
-
Nov 20, 2026, 00:02Andres Zuleta: Evaluating the RISE UP Trial Results on Mitapivat for Sickle Cell Disease
-
Nov 19, 2026, 23:57Greta Hametner: Preventing Maternal Cardiac Complications Through Preconception Iron and Thyroid Screening
-
Nov 19, 2026, 23:49Cyrus Shariat: Why Waiting for Lab Results Can Be Fatal in HIT
-
Nov 19, 2026, 22:24Erik Nelson: Low Iron Can Raise A1c without Changing Blood Sugar
-
Nov 19, 2026, 22:23Erwin Loh: Daily Iron Supplementation Reduces Iron-Deficiency Anaemia in Children and Adolescents